| JNTL Consumer Health II (Switzerland) GmbH - Nicorette Invisi 15 mg/ 16 h, transdermales Pflaster | | 58175 | | 02 | | Nicorette Invisi 15 mg/ 16 h | | transdermales Pflaster | | N07BA01 | | Nicotine | | 17.09.2009 | | |
| | Composition | | nicotinum 23.62 mg, triglycerida media, copolymerum methacrylatis butylati basicum, poly(ethylenis terephthalas), 2-ethylhexylacrylate/butyracryltate/vinylacetate/acrylic acid Copolymer (75:15:5:5) in ethylacetate/heptane (85:15), kalii hydroxidum, carmellosum natricum conexum, aluminii acetylacetonas, Drucktinte (braun): ad praeparationem pro 13.50 cm², cum liberatione 15 mg/16h. | | Packungsbestandteile | | Transdermal System | | | | | | Active Agent | Dose |
|---|
| Nicotine | 23.62 mg |
| | | | Inactive agents |
|---|
| 2-ethylhexylacrylate/butyracryltate/vinylacetate/acrylic acid Copolymer (75:15:5:5) in Ethylacetate/heptane (85:15) | | Aluminii Acetylacetonas | | Carmellosum Natricum Conexum | | Copolymerum Methacrylatis Butylati Basicum | | Kalii Hydroxidum | | Triglycerida Media |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 14 plaster(s) | | | D | | No |
|
|
